Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.

Clinical trial NCT00299780 · COMPLETED

Trial details

NCT number: NCT00299780
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Multiple Myeloma Acute Myelogenous Leukemia

Start date: 2004-07-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.